Mucinous Cystic Neoplasm (MCN)
A mucinous cystic neoplasm is a rare, cyst-forming pancreatic tumor characterized by two essential diagnostic components: mucin-producing epithelial cells and an underlying ovarian-type stroma, occurring predominantly in middle-aged women (9:1 female-to-male ratio) in the pancreatic body or tail. 1
Defining Histopathologic Features
The diagnosis of MCN requires both of the following components 1:
- Mucin-producing columnar epithelium with varying degrees of dysplasia (low-grade to high-grade)
- Ovarian-like stroma subjacent to the epithelial lining (this is the sine qua non for diagnosis)
The ovarian-type stroma expresses progesterone and estrogen receptors and can undergo luteinization similar to actual ovarian tissue 1. Without this stromal component, the lesion cannot be classified as an MCN.
Clinical Characteristics
Demographics and Location:
- Predominantly affects women aged 40-50 years at diagnosis 1
- Almost exclusively located in the pancreatic body or tail 1, 2
- Patients with invasive MCN present approximately a decade older (median ~55 years) 1
Presentation:
- Vague abdominal discomfort or epigastric mass sensation 1
- Circulating tumor markers (CEA, CA19-9) are normal unless invasive carcinoma is present 1
Imaging Features
MCNs appear as 1:
- Well-circumscribed cystic lesions with thick septae
- No communication with the pancreatic ductal system (key distinguishing feature from IPMNs)
- Main pancreatic duct is not dilated
- Cyst contents include mucin-rich or hemorrhagic fluid
Malignant Potential and Prognosis
Critical prognostic distinction 1:
- Non-invasive MCN: Nearly 100% disease-specific 5-year survival after resection
- MCN with invasive adenocarcinoma: 50-60% 5-year survival
Approximately one-third of reported MCNs are associated with invasive adenocarcinoma, usually ductal type 1. Unlike IPMNs, MCNs are typically unifocal lesions, which explains the excellent survival after complete surgical resection 1.
Distinction from IPMNs
On cytology (FNA), MCNs and IPMNs are indistinguishable because the diagnostic ovarian-type stroma is often not sampled or recognizable on smears 3. The term "mucinous neoplastic cyst" should be used for cytologic specimens, with a comment indicating both differentials are included 3.
Histologically, in areas lacking ovarian-type stroma, MCNs can appear identical to branch duct IPMNs 3.
Management Implications
Given the malignant potential and diagnostic uncertainty, complete surgical excision is recommended for all suspected MCNs 4. The risk of malignancy is largely proportional to lesion size 1. Many centers adopt a resectional approach when MCN is known or suspected, though some follow Sendai guidelines for IPMNs given the rarity of MCNs 1.
Surgical outcomes 5:
- Patients undergoing pancreatectomy have significantly better survival than those not operated (81.4 vs 6.6 months)
- Non-invasive (in situ) disease has prolonged survival compared to invasive disease
- Nodal status is the most important prognostic factor for invasive adenocarcinoma
Pathologic Reporting
A two-tiered grading system (low-grade vs high-grade dysplasia) is recommended 6. The terms "malignant MCN," "invasive MCN," or "mucinous cystadenocarcinoma" should be abandoned and replaced with "MCN with associated invasive carcinoma" per WHO and UICC recommendations 6.